Global scale PLG operates in 150+ countries with a large, multinational team and a wide client base across pharma, biotech, medical devices, nutrition, and cosmetics, presenting cross-sell and upsell opportunities across regulatory, safety, and digital transformation services.

Acquisitive growth Recent mergers and acquisitions (Heraxdirect, Stragen Pharma, Commercial Eyes, HCS) expand PLG’s geographic reach and service footprint, creating potential for integrated onboarding of clients and bundled offerings across regulatory affairs, market access, and lifecycle management.

Leadership change New CEO appointment and recent Chief Revenue Officer departure signal potential shifts in go-to-market strategy and priority areas; engage to align value proposition with refreshed leadership on growth in regulatory, digital, and AI-enabled solutions.

Financial footing Annual revenue in the high tens of millions to low hundreds of millions range with active private equity-backed growth; target opportunities include scale-up of regulatory compliance, pharmacovigilance, and digital transformation services for larger pharma accounts.

Tech-enabled services Adoption of cloud, AI tools, and digital platforms (ChatGPT, Pardot, Adobe, Office 365, Nginx) supports scalable service delivery; cross-sell advanced digital compliance, data analytics, and AI-enhanced pharmacovigilance to existing clients.